Allergan, Inc.
(NYSE: AGN)
Basic Financial Information (AGN)
- Company Type
- Public (NYSE: AGN)
- Fiscal Year-End
- December
- Financial Filings
- US SEC
Annual Income Statements (AGN)
All amounts in millions of British Pounds except share amounts
| Year |
Revenue |
Gross Profit |
Operating Income |
Total Net Income |
Diluted EPS (Net Income) |
| Dec 08 |
3,041.0 |
2,515.3 |
585.5 |
578.6 |
1.31 |
| Dec 07 |
1,972.2 |
1,635.1 |
380.1 |
499.3 |
0.81 |
| Dec 06 |
1,563.5 |
1,269.7 |
20.8 |
(127.4) |
(0.22) |
View more detailed Annual Financials, including:- Income Statement, Balance Sheet, and Cash Flow
Quarterly Income Statements (AGN)
All amounts in millions of British Pounds except share amounts
| Year |
Revenue |
Gross Profit |
Operating Income |
Total Net Income |
Diluted EPS (Net Income) |
| Sep 09 |
716.9 |
597.4 |
157.1 |
179.0 |
0.36 |
| Jun 09* |
684.5 |
564.4 |
166.8 |
176.1 |
0.35 |
| Jun 09 |
684.5 |
564.4 |
166.8 |
176.1 |
0.35 |
| Mar 09 |
708.7 |
583.6 |
58.3 |
45.0 |
0.11 |
| Mar 09 |
708.7 |
583.6 |
58.3 |
45.0 |
0.11 |
View more detailed Quarterly Financials, including:- Income Statement, Balance Sheet, and Cash Flow
Comparison To Industry & Market (AGN)
| Valuation |
Company |
Industry1
|
Market2
|
| Price/Sales Ratio |
4.17 |
16.67 |
7.24 |
| Price/Earnings Ratio |
32.26 |
384.62 |
26.32 |
| Price/Book Ratio |
4.01 |
3.57 |
6.96 |
| Price/Cash Flow Ratio |
18.25 |
80.65 |
45.05 |
View more detailed Comparison Data, including:- Side-by-side comparison of Allergan and its top 3 competitors
Top Competitors (AGN)
| |
Allergan |
Alcon |
Bausch & Lomb |
Johnson & Johnson |
| Annual Sales |
2,676.8 |
3,825.9 |
1,519.8 |
38,751.8 |
| Employees |
8,740 |
15,400 |
13,000 |
118,700 |
| Market Cap (£ mil.) |
11,090.9 |
27,085.2 |
0.0 |
106,170.4 |
View Competitive Landscape, including:- Side-by-side comparisons of profitability, operations, and per share data
